| This week's sponsor is Premier Research. | | | 7 Things to Watch When Recruiting for an Opioid Trial
Recruiting for an opioid trial? Consider seven key factors, such as avoiding drug abuse and diversion and minimizing screen failures. Find the details here. Premier Research. It's what we do. Best. |
Today's Rundown Tmunity nabs $100M for next-gen T-cell immunotherapies Amgen, Novartis’ migraine drug Aimovig hits endpoints in phase 3b ChemoCentryx eyes combinations after posting pancreatic cancer OS data New York sketches out $500M plan to build a biotech hub Right after Takeda deal, Denali medical director heads to rival Alkahest Disarm nabs Takeda, Pfizer executive to help neuro R&D goals Merck's Keytruda makes liver-cancer headway, putting BMS and Bayer on notice Featured Story | | | Tuesday, January 23, 2018 Tmunity is working to create safer and more effective T-cell therapies for solid tumors and blood cancers and is doing so in a "hybrid" manner, leveraging its relationship with the University of Pennsylvania with an eye toward expanding to its own facilities as the company matures. |
|
|
Top Stories Tuesday, January 23, 2018 With its PDUFA date approaching, Amgen and Novartis’ migraine drug has hit its primary and secondary endpoints in a study of migraine patients who have failed multiple other treatments. Tuesday, January 23, 2018 ChemoCentryx has posted 18-month survival data from a phase 1b trial of one of its CCR2 inhibitors in pancreatic cancer patients. Almost 30% of the participants were still alive 18 months after starting treatment on a combination of CCX872 and the chemotherapy regimen FOLFIRINOX. Tuesday, January 23, 2018 New York City is doubling down on its long-discussed, never-realized dream of building a biotech hub to rival South San Francisco and Boston. The latest iteration of the dream comes backed by a $500 million financing package and a goal to quadruple the amount of R&D space in the city. Tuesday, January 23, 2018 Hard on the heels of a big IPO and a lucrative deal with Takeda, one of Denali’s top executives is leaving the company to join anti-aging startup Alkahest. Tuesday, January 23, 2018 Preclinical neurological disease biotech Disarm has poached Big Pharma executive Thomas Engber, Ph.D., as its new SVP and head of neuropharmacology and translational sciences. Tuesday, January 23, 2018 Kidney cancer isn’t the only disease where Keytruda is moving in to challenge Bristol-Myers Squibb’s Opdivo. With some new data, the Merck drug is putting liver cancer in its sights, too. | This week's sponsor is IQVIA. | | | Discover a new path to your success via Human Data Science. IMS Health and Quintiles are now IQVIA™ – created to advance your pursuits of human science by unleashing the power of data science and human ingenuity. Join the journey today. Learn More. |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Agilent This Agilent intact protein analysis includes: Sponsored by: Seton Hall Don’t miss this educational program trusted by multi-national companies as part of their employee’s compliance training. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating in the Asia-Pacific region. Visit event page for session topics. Presented by: Patheon Download Patheon’s whitepaper to discover two main areas where a drug developer can face significant obstacles during biologics development and how by evaluating these capabilities, it can answer the critical question of whether its in-house strategy is ready for these uncertainties. Presented by: SDC and Stiris Research What do you do when timelines are missed, data is dirty, and everyone is pointing fingers? Join this webinar to learn how to prevent, identify, and implement a successful clinical trial rescue. Sponsored by: Veeva Systems Expanding into new markets places a spotlight on inefficient processes. Sponsored by: Veeva Systems Regulatory leaders share challenges and best practices from a lack of standardization, manual processes, and fragmented systems. Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Drug Approval, Manufacturing Quality & Regulation 2018 | Online TMF Operations: a Quality and Regulatory Approach March 19 - 21, 2018 | Berlin, Germany
Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA ICI Boston Summit 2018 March 19-21, 2018 | Boston, MA Field Service Medical February 26-28, 2018 | Hilton La Jolla, Torrey Pines, CA | 